Reset all filters
01 6PEMIGATINIB
02 9Pemigatinib
03 3Ponatinib
04 3Ponatinibhydroklorid
05 3Put It Away
06 1RETIFANLIMAB-DLWR
07 1RUXOLITINIB (RUXOLITINIB PHOSPHATE)
08 6RUXOLITINIB PHOSPHATE
09 1Retifanlimab
10 1Retifanlimab
11 1Ruxolitinib
12 2Ruxolitinib Phosphate
13 1TAFASITAMAB
14 2Tafasitamab
15 1Tafasitamabum
16 1axatilimab-csfr
Reset all filters
01 11INCYTE CORP
02 5INCYTE CORPORATION
03 9Incyte Biosciences Distribution B.V.
04 8Incyte Biosciences Distribution Bv
05 9Incyte Biosciences International S?rl
Reset all filters
01 1CREAM
02 1CREAM;TOPICAL
03 1Concentrate For Solution For Infusion
04 3Cream
05 9Film Coated Tablet
06 2INJECTABLE;INTRAVENOUS
07 1Injectable Solution
08 1POWDER FOR SOLUTION
09 1Powder For Concentrate For Infusion Solution
10 1Powder For Concentrate For Solution For Infusion
11 1Solution For Injection
12 3TABLET
13 8TABLET;ORAL
14 9Tablet
Reset all filters
01 11.5%/W/W
02 313.5MG
03 213.5mg
04 215MG
05 315mg
06 115mg/g
07 1200MG
08 1200MG/VIAL
09 2200mg
10 130MG
11 230mg
12 34.5MG
13 24.5mg
14 140mg
15 145MG
16 145mg
17 150 MG/ML
18 1500MG/20ML(25MG/ML)
19 1500mg
20 1500mg/20ml
21 39MG
22 19mg
23 1EQ 1.5% BASE
24 1EQ 10MG BASE
25 1EQ 15MG BASE
26 1EQ 20MG BASE
27 1EQ 25MG BASE
28 1EQ 5MG BASE
29 1Blank
Reset all filters
01 5Canada
02 8Spain
03 9Sweden
04 9Switzerland
05 11USA
Regulatory Info :
Registration Country : USA
Dosage Form : INJECTABLE;INTRAVENOUS
Brand Name : NIKTIMVO
Dosage Strength : 50 MG/ML
Packaging :
Approval Date :
Application Number : 761411
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : PEMAZYRE
Dosage Strength : 4.5MG
Packaging :
Approval Date : 2020-04-17
Application Number : 213736
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : PEMAZYRE
Dosage Strength : 9MG
Packaging :
Approval Date : 2020-04-17
Application Number : 213736
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : PEMAZYRE
Dosage Strength : 13.5MG
Packaging :
Approval Date : 2020-04-17
Application Number : 213736
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Tablet
Brand Name : Pemazyre
Dosage Strength : 13.5mg
Packaging :
Approval Date : 26/03/2021
Application Number : 20191122000062
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Tablet
Brand Name : Pemazyre
Dosage Strength : 4.5mg
Packaging :
Approval Date : 26/03/2021
Application Number : 20191122000048
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Dosage Form : Tablet
Brand Name : Pemazyre
Dosage Strength :
Packaging :
Approval Date : 26/03/2021
Application Number : 20191122000055
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Limited-Term
Registration Country : Switzerland
Dosage Form : Tablet
Brand Name : Pemazyre
Dosage Strength : 4.5mg
Packaging :
Approval Date : 13/07/2021
Application Number : 68143
Regulatory Info : Limited-Term
Registration Country : Switzerland
Regulatory Info : Limited-Term
Registration Country : Switzerland
Dosage Form : Tablet
Brand Name : Pemazyre
Dosage Strength : 9mg
Packaging :
Approval Date : 13/07/2021
Application Number : 68143
Regulatory Info : Limited-Term
Registration Country : Switzerland
Regulatory Info : Limited-Term
Registration Country : Switzerland
Dosage Form : Tablet
Brand Name : Pemazyre
Dosage Strength : 13.5mg
Packaging :
Approval Date : 13/07/2021
Application Number : 68143
Regulatory Info : Limited-Term
Registration Country : Switzerland